Samrat Pharmachem Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Samrat Pharmachem has a total shareholder equity of ₹650.0M and total debt of ₹84.5M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are ₹1.2B and ₹567.4M respectively. Samrat Pharmachem's EBIT is ₹36.4M making its interest coverage ratio 5.5. It has cash and short-term investments of ₹97.4M.
Informazioni chiave
13.0%
Rapporto debito/patrimonio netto
₹84.55m
Debito
| Indice di copertura degli interessi | 5.5x |
| Contanti | ₹97.36m |
| Patrimonio netto | ₹649.97m |
| Totale passività | ₹567.39m |
| Totale attività | ₹1.22b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 530125's short term assets (₹1.0B) exceed its short term liabilities (₹564.0M).
Passività a lungo termine: 530125's short term assets (₹1.0B) exceed its long term liabilities (₹3.4M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 530125 has more cash than its total debt.
Riduzione del debito: 530125's debt to equity ratio has reduced from 30.3% to 13% over the past 5 years.
Copertura del debito: 530125's debt is well covered by operating cash flow (111.3%).
Copertura degli interessi: 530125's interest payments on its debt are well covered by EBIT (5.5x coverage).